New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias

Stock Information for Heartbeam Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Heartbeam Inc.

HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo(TM) System for Synthesizing a 12-Lead ECG
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights
HeartBeam Reports Third Quarter 2023 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.